SLC22A2 gene 808 G/T variant is related to plasma lactate concentration in Chinese type 2 diabetics treated with metformin

被引:0
作者
Qing Li
Fang Liu
Tai-shan Zheng
Jun-ling Tang
Hui-juan Lu
Wei-ping Jia
机构
[1] Shanghai Jiaotong University affiliated Sixth People's Hospital,Department of Endocrinology and Metabolism
[2] Shanghai Clinical Center of Diabetes,undefined
[3] Shanghai Institute for Diabetes,undefined
[4] Shanghai Key Laboratory of Diabetes,undefined
来源
Acta Pharmacologica Sinica | 2010年 / 31卷
关键词
ASP-PCR; metformin; gene; organic cation transporter 2; lactate; single nucleotide polymorphism; type 2 diabetes mellitus;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:184 / 190
页数:6
相关论文
共 102 条
[1]  
Hundal RS(2003)Metformin: new understandings, new uses Drugs 63 1879-94
[2]  
Inzucchi SE(1994)Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations, a double- blind controlled study Diabetes Care 17 1100-9
[3]  
Hermann LS(2002)Interactions of N-tetraalkylammonium compounds and biguanides with a human renal organic cation tranporter (hOCT2) Pharm Res 19 1244-7
[4]  
Scherstén B(2005)Metformin is a superior substrate for renal organic cation tranporter OCT2 rather than hepatic OCT1 Drug Metab Pharmacokinet 20 379-86
[5]  
Bitzén PO(2002)Gene expression levels and immunolocalization of organic ion transproters in the human kidney J Am Soc Nephrol 13 866-74
[6]  
Kjellström T(1997)Cloning and characterization of two human polyspecific organic cation transporters DNA Cell Biol 16 871-81
[7]  
Lindgärde F(1999)Gender differences in expression of organic cation transporter OCT2 in rat kidney FEBS Letters 461 339-42
[8]  
Melander A(2000)Hormonal regulation of organic cation transporter OCT2 expression in rat kidney FEBS Letters 473 173-6
[9]  
Dresser MJ(2006)Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3 Pharm Res 23 697-704
[10]  
Xiao G(2003)Estimating the contribution of genes and environment to variation in renal drug clearance Pharmacogenetics 13 581-4